Nuclear factors: Roles related to mitochondrial deafness

Gene

Volumn 520, Issue 2, 2013, Pages 79-89

  Luo, Ling Feng ^a   Hou, Cong Cong ^a   Yang, Wan Xi ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Apoptosis; Hair cell; Hearing loss; Mitochondria; Nuclear gene; RNA modification

Indexed keywords

MITOCHONDRIAL DNA; NUCLEAR FACTOR;

BCS1L GENE; BIOGENESIS; C10ORF2 GENE; COX10 GENE; GENE; GENE MUTATION; GTPBP3 GENE; HARS2 GENE; HEARING IMPAIRMENT; HUMAN; MITOCHONDRIAL GENE; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL TRANSCRIPTION FACTOR B1 GENE; MODIFIER GENE; MPV17 GENE; MTO1 GENE; OPA1 GENE; PHENOTYPE; POLG1 GENE; PRENYLDIPHOSPHATE SYNTHASE SUBUNIT 1 GENE; PRIORITY JOURNAL; REVIEW; RRM2B GENE; SECOND MITOCHONDRIA DERIVED ACTIVATOR OF CASPASE GENE; SUCLA2 GENE; TRANSLOCASE OF MITOCHONDRIAL INNER MEMBRANE 8A GENE; TRMU GENE;

ANIMALS; DNA, MITOCHONDRIAL; GENES, MODIFIER; HEARING LOSS; HUMANS; MITOCHONDRIAL DISEASES; MITOCHONDRIAL PROTEINS; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 84876311834     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.03.041     Document Type: Review

References (160)

1. Acham-Roschitz B., et al. A novel mutation of the RRM2B gene in an infant with early fatal encephalomyopathy, central hypomyelination, and tubulopathy. Mol. Genet. Metab. 2009, 98:300-304.
2. Aguirre L.A., et al. A novel mutation in the gene encoding TIMM8a, a component of the mitochondrial protein translocase complexes, in a Spanish familial case of deafness-dystonia (Mohr-Tranebjaerg) syndrome. Am. J. Med. Genet. A 2006, 140A:392-397.
3. Aguirre L.A., et al. A Spanish sporadic case of deafness-dystonia (Mohr-Tranebjaerg) syndrome with a novel mutation in the gene encoding TIMM8a, a component of the mitochondrial protein translocase complexes. Neuromuscul. Disord. 2008, 18:979-981.
4. AlSaman A., Tomoum H., Invernizzi F., Zeviani M. Hepatocerebral form of mitochondrial DNA depletion syndrome due to mutation in MPV17 gene. Saudi J. Gastroenterol. 2012, 18:285-289.
5. Amati-Bonneau P., et al. OPA1 R445H mutation in optic atrophy associated with sensorineural deafness. Ann. Neurol. 2005, 58:958-963.
6. Amati-Bonneau P., et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy plus phenotypes. Brain 2008, 131:338-351.
7. Antonicka H., et al. Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency. Hum. Mol. Genet. 2003, 12:2693-2702.
8. Arnoult D., et al. Bax/Bak-dependent release promotes of DDP/TIMM8a promotes Drp1-mediated mitochondrial fission and mitoptosis during programmed cell death. Curr. Biol. 2005, 15:2112-2118.
9. Attardi G., Schatz G. Biogenesis of mitochondria. Annu. Rev. Cell Biol. 1988, 4:289-333.
10. Ballana E., Mercader J.M., Fischel-Ghodsian N., Estivill X. MRPS18CP2 alleles and DEFA3 absence as putative chromosome 8p23.1 modifiers of hearing loss due to mtDNA mutation A1555G in the 12S rRNA gene. BMC Med. Genet. 2007, 8.
11. Ban T., Heymann J.A.W., Song Z., Hinshaw J.E., Chan D.C. OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation. Hum. Mol. Genet. 2010, 19:2113-2122.
12. Baum H., Rieske J.S., Silman H.I., Lipton S.H. On mechanism of electron transfer in complex 3 of electron transfer chain. Proc. Natl. Acad. Sci. U. S. A. 1967, 57:798. (&).
13. Bette S., Ulrike Z., Bernd W., Knipper M. OPA1, the disease gene for optic atrophy type Kjer, is expressed in the inner ear. Histochem. Cell Biol. 2007, 128:421-430.
14. Binder J., et al. Clinical and molecular findings in a patient with a novel mutation in the deafness-dystonia peptide (DDP1) gene. Brain 2003, 126:1814-1820.
15. Bjorklund S., Skog S., Tribukait B., Thelander L. S-phase-specific expression of mammalian ribonucleotide reductase-R1 and reductase-R2 subunit messenger-RNAs. Biochemistry 1990, 29:5452-5458.
16. Blesa J.R., Solano A., Briones P., Prieto-Ruiz J.A., Hernandez-Yago J., Coria F. Molecular genetics of a patient with Mohr-Tranebjaerg syndrome due to a new mutation in the DDP1 gene. Neruomol. Med. 2007, 9:285-291.
17. Boehringer D., O'Farrell H.C., Rife J.P., Ban N. Structural insights into methyltransferase KsgA function in 30S ribosomal subunit biogenesis. J. Biol. Chem. 2012, 287:10453-10459.
18. Bohme S., Meyer S., Kruger A., Steinhoff H.J., Wittinghofer A., Klare J.P. Stabilization of G domain conformations in the tRNA-modifying MnmE-GidA complex observed with double electron electron resonance spectroscopy. J. Biol. Chem. 2010, 285:16991-17000.
19. Bosch N., Morell M., Ponsa I., Mercader J.M., Armengol L., Estivill X. Nucleotide, cytogenetic and expression impact of the human chromosome 8p23.1 Inversion Polymorphism. PLoS One 2009, 4.
20. Bregeon D., Colot V., Radman M., Taddei F. Translational misreading: a tRNA modification counteracts a+2 ribosomal frameshift. Genes Dev. 2001, 15:2295-2306.
21. Bu X.D., Shohat M., Jaber L., Rotter J.I. A form of sensorineural deafness is determined by a mitochondrial and an autosomal locus - evidence from pedigree segregation analysis. Genet. Epidemiol. 1993, 10:3-15.
22. Bykhovskaya Y., et al. Candidate locus for a nuclear modifier gene for maternally inherited deafness. Am. J. Hum. Genet. 2000, 66:1905-1910.
23. Bykhovskaya Y., et al. Modifier locus for mitochondrial DNA disease: linkage and linkage disequilibrium mapping of a nuclear modifier gene for maternally inherited deafness. Genet. Med. 2001, 3:177-180.
24. Bykhovskaya Y., et al. Human mitochondrial transcription factor B1 as a modifier gene for hearing loss associated with the mitochondrial A1555G mutation. Mol. Genet. Metab. 2004, 82:27-32.
25. Bykhovskaya Y., et al. Phenotype of non-syndromic deafness associated with the mitochondrial A1555G mutation is modulated by mitochondrial RNA modifying enzymes MTO1 and GTPBP3. Mol. Genet. Metab. 2004, 83:199-206.
26. Carrozzo R., et al. SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain 2007, 130:862-874.
27. Caughey W.S., Smythe G.A., Okeeffe D.H., Maskasky J.E., Smith M.L. Heme-a of cytochrome-c oxidase - structure and properties - comparisons with heme-b, heme-c and heme-s and derivatives. J. Biol. Chem. 1975, 250:7602-7622.
28. Chai J.J., Du C.Y., Wu J.W., Kyin S., Wang X.D., Shi Y.G. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 2000, 406:855-862.
29. Cheng J., et al. Functional mutation of SMAC/DIABLO, encoding a mitochondrial proapoptotic protein, causes human progressive hearing loss DFNA64. Am. J. Hum. Genet. 2011, 89:56-66.
30. Chevrollier A., et al. Standardized mitochondrial analysis gives new insights into mitochondrial dynamics and OPA1 function. Int. J. Biochem. Cell Biol. 2012, 44:980-988.
31. Cipolat S., de Brito O.M., Dal Zilio B., Scorrano L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:15927-15932.
32. Coenen M.J.H., et al. Cytochrome c oxidase biogenesis in a patient with a mutation in COX10 gene. Ann. Neurol. 2004, 56:560-564.
33. Cohen B.H., Naviaux R.K. The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders. Methods 2010, 51:364-373.
34. Colby G., Tu M., Tzagoloff A. MTO1 codes for a mitochondrial protein required for respiration in paromomycin-resistant mutants of Saccharomyces cerevisiae. J. Biol. Chem. 1998, 273:27945-27952.
35. Cotney J., Shadel G.S. Evidence for an early gene duplication event in the evolution of the mitochondrial transcription factor B family and maintenance of rRNA methyltransferase activity in human mtTFB1 and mtTFB2. J. Mol. Evol. 2006, 63:707-717.
36. Cotney J., Mckay S.E., Shadel G.S. Elucidation of separate, but collaborative functions of the rRNA methyltransferase-related human mitochondrial transcription factors B1 and B2 in mitochondrial biogenesis reveals new insight into maternally inherited deafness. Hum. Mol. Genet. 2009, 18:2670-2682.
37. Cruciat C.M., Hell K., Folsch H., Neupert W., Stuart R.A. Bcs1p, an AAA-family member, is a chaperone for the assembly of the cytochrome bc(1) complex. EMBO J. 1999, 18:5226-5233.
38. de Moraes V.C.S., Alexandrino F., Andrade P.B., Camara M.F., Sartorato E.L. Study of modifiers factors associated to mitochondrial mutations in individuals with hearing impairment. Biochem. Biophys. Res. Commun. 2009, 381:210-213.
39. Decoster E., Vassal A., Faye G. MSS1, A nuclear-encoded mitochondrial gtpase involved in the expression of COX1 subunit of cytochrome-c-oxidase. J. Mol. Biol. 1993, 232:79-88.
40. Delettre C., et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 2000, 26:207-210.
41. Demirci H., et al. Modification of 16S ribosomal RNA by the KsgA methyltransferase restructures the 30S subunit to optimize ribosome function. RNA 2010, 16:2319-2324.
42. Desai P.M., Culver G.M., Rife J.P. Site-directed mutants of 16S rRNA reveal important RNA domains for KsgA function and 30S subunit assembly. Biochemistry 2011, 50:854-863.
43. Deveraux Q.L., Reed T.C. IAP family proteins - suppressors of apoptosis. Genes Dev. 1999, 13:239-252.
44. Di Giovanni S., et al. Coenzyme Q(10) reverses pathological phenotype and reduces apoptosis in familial CoQ(10) deficiency. Neurology 2001, 57:515-518.
45. Diaz F., Thomas C.K., Garcia S., Hernandez D., Moraes C.T. Mice lacking COX10 in skeletal muscle recapitulate the phenotype of progressive mitochondrial myopathies associated with cytochrome c oxidase deficiency. Hum. Mol. Genet. 2005, 14:2737-2748.
46. Diaz F., Kotarsky H., Fellman V., Moraes C.T. Mitochondrial disorders caused by mutations in respiratory chain assembly factors. Semin. Fetal Neonatal. Med. 2011, 16:197-204.
47. Dror A.A., Avraham K.B. Hearing loss: mechanisms revealed by genetics and cell biology. Annu. Rev. Genet. 2009, 43:411-437.
48. Du C.Y., Fang M., Li Y.C., Li L., Wang X.D. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000, 102:33-42.
49. Dundar H., et al. Identification of a novel Twinkle mutation in a family with infantile onset spinocerebellar ataxia by whole exome sequencing. Pediatr. Neurol. 2012, 46:172-177.
50. Duvezin-Caubet S., et al. Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J. Biol. Chem. 2006, 281:37972-37979.
51. Echaniz-Laguna A., et al. A novel variation in the Twinkle linker region causing late-onset dementia. Neurogenetics 2010, 11:21-25.
52. Elachouri G., et al. OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res. 2011, 21:12-20.
53. Elpeleg O., et al. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am. J. Hum. Genet. 2005, 76:1081-1086.
54. Engl G., Florian S., Tranebjaerg L., Rapaport D. Alterations in expression levels of deafness dystonia protein 1 affect mitochondrial morphology. Hum. Mol. Genet. 2012, 21:287-299.
55. Falkenberg M., Gaspari M., Rantanen A., Trifunovic A., Larsson N.G., Gustafsson C.M. Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA. Nat. Genet. 2002, 31:289-294.
56. Fernandez-Vizarra E., et al. Impaired complex III assembly associated with BCS1L gene mutations in isolated mitochondrial encephalopathy. Hum. Mol. Genet. 2007, 16:1241-1252.
57. Fischel-Ghodsian N. Mitochondrial RNA processing and translation: Link between mitochondrial mutations and hearing loss?. Mol. Genet. Metab. 1998, 65:97-104.
58. Frezza C., et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 2006, 126:177-189.
59. 2+ signaling. PLoS One 2011, 6.
60. Fulda S., Vucic D. Targeting IAP proteins for therapeutic intervention in cancer. Nat. Rev. Drug Discov. 2012, 11:109-124.
61. Ghezzi D., et al. Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. Am. J. Hum. Genet. 2012, 90:1079-1087.
62. Graziewicz M.A., Longley M.J., Copeland W.C. DNA polymerase gamma in mitochondrial DNA replication and repair. Chem. Rev. 2006, 106:383-405.
63. Guan M.X., FischelGhodsian N., Attardi G. Biochemical evidence for nuclear gene involvement phenotype of non-syndromic deafness associated with mitochondrial 12S rRNA mutation. Hum. Mol. Genet. 1996, 5:963-971.
64. Guan M.X., Fischel-Ghodsian N., Attardi G. Nuclear background determines biochemical phenotype in the deafness-associated mitochondrial 12S rRNA mutation. Hum. Mol. Genet. 2001, 10:573-580.
65. Guan M.X., et al. Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am. J. Hum. Genet. 2006, 79:291-302.
66. Guittet O., et al. Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells. J. Biol. Chem. 2001, 276:40647-40651.
67. Guo S.Y., Tabor S., Richardson C.C. The linker region between the helicase and primase domains of the bacteriophage T7 gene 4 protein is critical for hexamer formation. J. Biol. Chem. 1999, 274:30303-30309.
68. Hakansson P., Hofer A., Thelander L. Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells. J. Biol. Chem. 2006, 281:7834-7841.
69. Hakonen A.H., Isohanni P., Paetau A., Herva R., Suomalainen A., Loennqvist T. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 2007, 130:3032-3040.
70. Hinson J.T., et al. Missense mutations in the BCS1L gene as a cause of the Bjornstad syndrome. N. Engl. J. Med. 2007, 356:809-819.
71. Hofmann S., et al. The C66W mutation in the deafness dystonia peptide 1 (DDP1) affects the formation of functional DDP1 center dot TIM13 complexes in the mitochondrial intermembrane space. J. Biol. Chem. 2002, 277:23287-23293.
72. Hollox E.J., Barber J.C.K., Brookes A.J., Armour J.A.L. Defensins and the dynamic genome: what we can learn from structural variation at human chromosome band 8p23.1. Genome Res. 2008, 18:1686-1697.
73. Huang T.S., Santarelli R., Starr A. Mutation of OPA1 gene causes deafness by affecting function of auditory nerve terminals. Brain Res. 2009, 1300:97-104.
74. Hudson G., Chinnery P.F. Mitochondrial DNA polymerase-gamma and human disease. Hum. Mol. Genet. 2006, 15:R244-R252.
75. Hudson G., et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008, 131:329-337.
76. Iida R., Yasuda T., Tsubota E., Takatsuka H., Matsuki T., Kishi K. Human Mpv17-like protein is localized in peroxisomes and regulates expression of antioxidant enzymes. Biochem. Biophys. Res. Commun. 2006, 344:948-954.
77. Jonard L., et al. Molecular diagnosis of genetic deafness. Clin. Biochem. 2011, 44:510-511.
78. Jyonouchi H., Geng L., Toruner G.A., Vinekar K., Feng D., Fitzgerald-Bocarsly P. Monozygous twins with a microdeletion syndrome involving BTK, DDP1, and two other genes; evidence of intact dendritic cell development and TLR responses. Eur. J. Pediatr. 2008, 167:317-321.
79. Kambampati R., Lauhon C.T. MnmA and IscS are required for in vitro 2-thiouridine biosynthesis in Escherichia coli. Biochemistry 2003, 42:1109-1117.
80. Kim H.J., Khalimonchuk O., Smith P.M., Winge D.R. Structure, function, and assembly of heme centers in mitochondrial respiratory complexes. Biochim. Biophys. Acta, Mol. Cell Res. 2012, 1823:1604-1616.
81. Koehler C.M., Leuenberger D., Merchant S., Renold A., Junne T., Schatz G. Human deafness dystonia syndrome is a mitochondrial disease. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:2141-2146.
82. Kolberg M., Strand K.R., Graff P., Andersson K.K. Structure, function, and mechanism of ribonucleotide reductases. Biochim. Biophys. Acta, Proteins Proteomics 2004, 1699:1-34.
83. Kollberg G., et al. A novel homozygous RRM2B missense mutation in association with severe mtDNA depletion. Neuromuscul. Disord. 2009, 19:147-150.
84. Komulainen T., et al. POLG1 p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype. BMC Neurol. 2010, 10.
85. Korhonen J.A., Gaspari M., Falkenberg M. TWINKLE has 5'→3' DNA helicase activity and is specifically stimulated by mitochondrial single-stranded DNA-binding protein. J. Biol. Chem. 2003, 278:48627-48632.
86. Korhonen J.A., Pham X.H., Pellegrini M., Falkenberg M. Reconstitution of a minimal mtDNA replisome in vitro. EMBO J. 2004, 23:2423-2429.
87. Krick S., et al. Mpv17l protects against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 protease. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14106-14111.
88. Krohn K., et al. Immunochemical characterization of a novel mitochondrially located protein encoded by a nuclear gene within the DFNB8/10 critical region on 21q22.3. Biochem. Biophys. Res. Commun. 1997, 238:806-810.
89. Kumar A., Kaur H., Devi P., Mohan V. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacol. Ther. 2009, 124:259-268.
90. Lee Y.J., Jeong S.Y., Karbowski M., Smith C.L., Youle R.J. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol. Biol. Cell 2004, 15:5001-5011.
91. Lee Y.-S., Kennedy W.D., Yin Y.W. Structural insight into processive human mitochondrial DNA synthesis and disease-related polymerase mutations. Cell 2009, 139:312-324.
92. Li X.M., Guan M.X. A human mitochondrial GTP binding protein related to tRNA modification may modulate phenotypic expression of the deafness-associated mitochondrial 12S rRNA mutation. Mol. Cell. Biol. 2002, 22:7701-7711.
93. Li X.M., Li R.H., Lin X.H., Guan M.X. Isolation and characterization of the putative nuclear modifier gene MTO1 involved in the pathogenesis of deafness-associated mitochondrial 12S rRNA A1555G mutation. J. Biol. Chem. 2002, 277:27256-27264.
94. Litonin D., et al. Human mitochondrial transcription revisited only TFAM and TFB2M are required for transcription of the mitochondrial genes in vitro. J. Biol. Chem. 2010, 285:18129-18133.
95. Liu X.Y., et al. The ribonucleotide reductase subunit M2B subcellular localization and functional importance for DNA replication in physiological growth of KB cells. Biochem. Pharmacol. 2005, 70:1288-1297.
96. Longley M.J., Humble M.M., Sharief F.S., Copeland W.C. Disease variants of the human mitochondrial DNA helicase encoded by C10orf2 differentially alter protein stability, nucleotide hydrolysis, and helicase activity. J. Biol. Chem. 2010, 285:29690-29702.
97. Martinez-Vicente M., et al. Effects of mutagenesis in the switch I region and conserved arginines of Escherichia coli MnmE protein, a GTPase involved in tRNA modification. J. Biol. Chem. 2005, 280:30660-30670.
98. Matthijs G., Claes S., LongoMbenza B., Cassiman J.J. Non-syndromic deafness associated with a mutation and a polymorphism in the mitochondrial 12S ribosomal RNA gene in a large Zairean pedigree. Eur. J. Hum. Genet. 1996, 4:46-51.
99. Metodiev M.D., et al. Methylation of 12S rRNA is necessary for in vivo stability of the small subunit of the mammalian mitochondrial ribosome. Cell Metab. 2009, 9:386-397.
100. Meyer S., Bohme S., Kruger A., Steinhoff H.J., Klare J.P., Wittinghofer A. Kissing G domains of MnmE monitored by X-ray crystallography and pulse electron paramagnetic resonance spectroscopy. PLoS Biol. 2009, 7.
101. Meyer S., Wittinghofer A., Versees W. G-domain dimerization orchestrates the tRNA wobble modification reaction in the MnmE/GidA complex. J. Mol. Biol. 2009, 392:910-922.
102. Mollet J., et al. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J. Clin. Invest. 2007, 117:765-772.
103. Moran M., et al. Cellular pathophysiological consequences of BCS1L mutations in mitochondrial complex III enzyme deficiency. Hum. Mutat. 2010, 31:930-941.
104. Morava E., et al. Dystonia and deafness due to SUCLA2 defect; clinical course and biochemical markers in 16 children. Mitochondrion 2009, 9:438-442.
105. Morton N.E. Genetic epidemiology of hearing impairment. Ann. N. Y. Acad. Sci. 1991, 630:16-31.
106. Muller M., et al. Loss of auditory function in transgenic Mpvl7-deficient mice. Hear. Res. 1997, 114:259-263.
107. Munoz-Pinedo C., Guio-Carrion A., Goldstein J.C., Fitzgerald P., Newmeyer D.D., Green D.R. Different mitochondrial-intermembrane space proteins are released during apoptosis in a manner that is coordinately initiated but can vary in duration. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:11573-11578.
108. Naderi J., et al. Water-soluble formulation of Coenzyme Q(10) inhibits Bax-induced destabilization of mitochondria in mammalian cells. Apoptosis 2006, 11:1359-1369.
109. Neupert W. Protein import into mitochondria. Annu. Rev. Biochem. 1997, 66:863-917.
110. Neupert W., Herrmann J.M. Translocation of proteins into mitochondria. Annu. Rev. Biochem. 2007, 723-749.
111. Ostergaard E., et al. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain 2007, 130:853-861.
112. Payne M., et al. Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1. Am. J. Ophthalmol. 2004, 138:749-755.
113. Pierce S.B., et al. Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:6543-6548.
114. Pontarin G., et al. Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:17801-17806.
115. Quinzii C.M., et al. Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ(10) deficiency. FASEB J. 2008, 22:1874-1885.
116. Quinzii C.M., et al. Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ(10) deficiency. FASEB J. 2010, 24:3733-3743.
117. Raimundo N., et al. Mitochondrial stress engages E2F1 apoptotic signaling to cause deafness. Cell 2012, 148:716-726.
118. Remes A.M., et al. Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene. Parkinsonism Relat. Disord. 2008, 14:652-654.
119. Roesch K., Curran S.P., Tranebjaerg L., Koehler C.M. Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex. Hum. Mol. Genet. 2002, 11:477-486.
120. Roesch K., Hynds P.J., Varga R., Tranebjaerg L., Koehler C.M. The calcium-binding aspartate/glutamate carriers, citrin and aralar1, are new substrates for the DDP1/TIMM8a-TIMM13 complex. Hum. Mol. Genet. 2004, 13:2101-2111.
121. Rothbauer U., et al. Role of the deafness dystonia peptide 1 (DDP1) in import of human Tim23 into the inner membrane of mitochondria. J. Biol. Chem. 2001, 276:37327-37334.
122. Sasarman F., Antonicka H., Horvath R., Shoubridge E.A. The 2-thiouridylase function of the human MTU1 (TRMU) enzyme is dispensable for mitochondrial translation. Hum. Mol. Genet. 2011, 20:4634-4643.
123. Schara U., et al. Acute liver failure with subsequent cirrhosis as the primary manifestation of TRMU mutations. J. Inherit. Metab. Dis. 2011, 34:197-201.
124. Scott H.S., et al. Characterization of a novel gene, C21orf2, an human chromosome 21q22.3 and its exclusion as the APECED gene by mutation analysis. Genomics 1998, 47:64-70.
125. Seidel-Rogol B.L., McCulloch V., Shadel G.S. Human mitochondrial transcription factor B1 methylates ribosomal RNA at a conserved stem-loop. Nat. Genet. 2003, 33:23-24.
126. Sen D., Nandakumar D., Tang G.-Q., Patel S.S. Human mitochondrial DNA helicase TWINKLE is both an unwinding and annealing helicase. J. Biol. Chem. 2012, 287:14545-14556.
127. Shearer A.E., Hildebrand M.S., Sloan C.M., Smith R.J.H. Deafness in the genomics era. Hear. Res. 2011, 282:1-9.
128. Someya S., et al. Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:19432-19437.
129. Song Z., Ghochani M., McCaffery J.M., Frey T.G., Chan D.C. Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol. Biol. Cell 2009, 20:3525-3532.
130. Soto I.C., Fontanesi F., Liu J., Barrientos A. Biogenesis and assembly of eukaryotic cytochrome c oxidase catalytic core. Biochim. Biophys. Acta Bioenerg. 2012, 1817:883-897.
131. Spelbrink J.N., et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene LF-like protein localized in mitochondria. Nat. Genet. 2001, 28:223-231.
132. Spinazzola A., et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat. Genet. 2006, 38:570-575.
133. Srinivasula S.M., Datta P., Fan X.J., Fernandes-Alnemri T., Huang Z.W., Alnemri E.S. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J. Biol. Chem. 2000, 275:36152-36157.
134. Takata A., et al. Exome sequencing identifies a novel missense variant in RRM2B associated with autosomal recessive progressive external ophthalmoplegia. Genome Biol. 2011, 12.
135. Tanaka H., et al. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 2000, 404:42-49.
136. Tranebjaerg L., Hamel B.C.J., Gabreels F.J.M., Renier W.O., Van Ghelue M. A de novo missense mutation in a critical domain of the X-linked DDP gene causes the typical deafness-dystonia-optic atrophy syndrome. Eur. J. Hum. Genet. 2000, 8:464-467.
137. Tyynismaa H., Ylikallio E., Patel M., Molnar M.J., Haller R.G., Suomalainen A. A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions. Am. J. Hum. Genet. 2009, 85:290-295.
138. Umeda N., Suzuki T., Yukawa M., Ohya Y., Shindo H., Watanabe K. Mitochondria-specific RNA-modifying enzymes responsible for the biosynthesis of the wobble base in mitochondrial tRNAs - implications for the molecular pathogenesis of human mitochondrial diseases. J. Biol. Chem. 2005, 280:1613-1624.
139. Uusimaa J., et al. Reversible infantile respiratory chain deficiency is a unique, genetically heterogenous mitochondrial disease. J. Med. Genet. 2011, 48:660-668.
140. Valnot I., et al. A mutation in the human heme A: farnesyltransferase gene (COX10) causes cytochrome c oxidase deficiency. Hum. Mol. Genet. 2000, 9:1245-1249.
141. Vande Walle L., et al. Proteome-wide identification of HtrA2/Omi substrates. J. Proteome Res. 2007, 6:1006-1015.
142. Verhagen A.M., et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000, 102:43-53.
143. Villarroya M., et al. Characterization of human GTPBP3, a GTP-binding protein involved in mitochondrial tRNA modification. Mol. Cell. Biol. 2008, 28:7514-7531.
144. Visapaa I., et al. GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am. J. Hum. Genet. 2002, 71:863-876.
145. Wang X., Yan Q., Guan M.-X. Deletion of the MTO2 gene related to tRNA modification causes a failure in mitochondrial RNA metabolism in the yeast Saccharomyces cerevisiae. FEBS Lett. 2007, 581:4228-4234.
146. Wang X., Yan Q., Guan M.-X. Combination of the loss of cmnm U-5(34) with the lack of s(2)U(34) modifications of tRNA(Lys), tRNA(Glu), and tRNA(Gln) altered mitochondrial biogenesis and respiration. J. Mol. Biol. 2010, 395:1038-1048.
147. Weiher H., Noda T., Gray D.A., Sharpe A.H., Jaenisch R. Transgenic mouse model of kidney-disease - insertional inactivation of ubiquitously expressed gene leads to nephrotic syndrome. Cell 1990, 62:425-434.
148. Williams P.A., Piechota M., von Ruhland C., Taylor E., Morgan J.E., Votruba M. Opa1 is essential for retinal ganglion cell synaptic architecture and connectivity. Brain 2012, 135:493-505.
149. Wortmann S.B., et al. Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness. Nat. Genet. 2012, 44:797-802.
150. Xu Z., O'Farrell H.C., Rife J.P., Culver G.M. A conserved rRNA methyltransferase regulates ribosome biogenesis. Nat. Struct. Mol. Biol. 2008, 15:534-536.
151. Yan Q.F., Guan M.X. Identification and characterization of mouse TRMU gene encoding the mitochondrial 5-methylaminomethyl-2-thiouridylate-methyltransferase. Biochim. Biophys. Acta, Gene Struct. Expr. 2004, 1676:119-126.
152. Yan Q.F., Li X.M., Faye R., Guan M.X. Mutations in MTO2 related to tRNA modification impair mitochondrial gene expression and protein synthesis in the presence of a paromomycin resistance mutation in mitochondrial 15S rRNA. J. Biol. Chem. 2005, 280:29151-29157.
153. Yan Q.F., et al. Human TRMU encoding the mitochondrial 5-methylaminomethyl-2-thiouridylate-methyltransferase is a putative nuclear modifier gene for the phenotypic expression of the deafness-associated 12S rRNA mutations. Biochem. Biophys. Res. Commun. 2006, 342:1130-1136.
154. Yasukawa T., et al. Wobble modification deficiency in mutant tRNAs in patients with mitochondrial diseases. FEBS Lett. 2005, 579:2948-2952.
155. Yim L., Moukadiri I., Bjork G.R., Armengod M.E. Further insights into the tRNA modification process controlled by proteins MnmE and GidA of Escherichia coli. Nucleic Acids Res. 2006, 34:5892-5905.
156. Yu-Wai-Man P., et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain 2010, 133:771-786.
157. Zeharia A., et al. Acute infantile liver failure due to mutations in the TRMU gene. Am. J. Hum. Genet. 2009, 85:401-407.
158. Zum Gottesberge A.M.M., Reuter A., Weiher H. Inner ear defect similar to Alport's syndrome in the glomerulosclerosis mouse model Mpv17. Eur. Arch. Otorhinolaryngol. 1996, 253:470-474.
159. Zum Gottesberge A.M.M., Massing T., Hansen S. Missing mitochondrial Mpv17 gene function induces tissue-specific cell-death pathway in the degenerating inner ear. Cell Tissue Res. 2012, 347:343-356.
160. Zwacka R.M., et al. The glomerulosclerosis gene MPV17 encodes a peroxisomal protein producing reactive oxygen species. EMBO J. 1994, 13:5129-5134.